BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1518 related articles for article (PubMed ID: 21880712)

  • 1. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype.
    Coppé JP; Rodier F; Patil CK; Freund A; Desprez PY; Campisi J
    J Biol Chem; 2011 Oct; 286(42):36396-403. PubMed ID: 21880712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P16
    Jin J; Tao J; Gu X; Yu Z; Wang R; Zuo G; Li Q; Lv X; Miao D
    Sci Rep; 2017 Aug; 7(1):7502. PubMed ID: 28790310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts.
    Stein GH; Drullinger LF; Soulard A; Dulić V
    Mol Cell Biol; 1999 Mar; 19(3):2109-17. PubMed ID: 10022898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted clearance of p21- but not p16-positive senescent cells prevents radiation-induced osteoporosis and increased marrow adiposity.
    Chandra A; Lagnado AB; Farr JN; Doolittle M; Tchkonia T; Kirkland JL; LeBrasseur NK; Robbins PD; Niedernhofer LJ; Ikeno Y; Passos JF; Monroe DG; Pignolo RJ; Khosla S
    Aging Cell; 2022 May; 21(5):e13602. PubMed ID: 35363946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue specificity of senescent cell accumulation during physiologic and accelerated aging of mice.
    Yousefzadeh MJ; Zhao J; Bukata C; Wade EA; McGowan SJ; Angelini LA; Bank MP; Gurkar AU; McGuckian CA; Calubag MF; Kato JI; Burd CE; Robbins PD; Niedernhofer LJ
    Aging Cell; 2020 Mar; 19(3):e13094. PubMed ID: 31981461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term growth arrest of PUVA-treated fibroblasts in G2/M in the absence of p16(INK4a) p21(CIP1) or p53.
    Ma W; Hommel C; Brenneisen P; Peters T; Smit N; Sedivy J; Scharffetter-Kochanek K; Wlaschek M
    Exp Dermatol; 2003 Oct; 12(5):629-37. PubMed ID: 14705804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.
    Murakami T; Inagaki N; Kondoh H
    Front Endocrinol (Lausanne); 2022; 13():869414. PubMed ID: 35432205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell analysis of p16(INK4a) and p21(WAF1) expression suggests distinct mechanisms of senescence in normal human and Li-Fraumeni Syndrome fibroblasts.
    Mirzayans R; Andrais B; Scott A; Paterson MC; Murray D
    J Cell Physiol; 2010 Apr; 223(1):57-67. PubMed ID: 20039273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence.
    Haferkamp S; Tran SL; Becker TM; Scurr LL; Kefford RF; Rizos H
    Aging (Albany NY); 2009 May; 1(6):542-56. PubMed ID: 20157537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism.
    Wang R; Yu Z; Sunchu B; Shoaf J; Dang I; Zhao S; Caples K; Bradley L; Beaver LM; Ho E; Löhr CV; Perez VI
    Aging Cell; 2017 Jun; 16(3):564-574. PubMed ID: 28371119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two mechanisms underlying the loss of p16(Ink4a) function are associated with distinct tumorigenic consequences for WS MEFs escaping from senescence.
    Wu X; Jia S; Zhang X; Si X; Tang W; Luo Y
    Mech Ageing Dev; 2012 Aug; 133(8):549-55. PubMed ID: 22813853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2FBP1 antagonizes the p16(INK4A)-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability.
    Fukuyo Y; Takahashi A; Hara E; Horikoshi N; Pandita TK; Nakajima T
    Int J Oral Sci; 2011 Oct; 3(4):200-8. PubMed ID: 22010578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p21Waf1/Cip1 plays a critical role in modulating senescence through changes of DNA methylation.
    Zheng QH; Ma LW; Zhu WG; Zhang ZY; Tong TJ
    J Cell Biochem; 2006 Aug; 98(5):1230-48. PubMed ID: 16514663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cells exhibiting strong
    Liu JY; Souroullas GP; Diekman BO; Krishnamurthy J; Hall BM; Sorrentino JA; Parker JS; Sessions GA; Gudkov AV; Sharpless NE
    Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2603-2611. PubMed ID: 30683717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p16
    Novais EJ; Diekman BO; Shapiro IM; Risbud MV
    Matrix Biol; 2019 Sep; 82():54-70. PubMed ID: 30811968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, "fueling" tumor growth via paracrine interactions, without an increase in neo-angiogenesis.
    Capparelli C; Chiavarina B; Whitaker-Menezes D; Pestell TG; Pestell RG; Hulit J; Andò S; Howell A; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Oct; 11(19):3599-610. PubMed ID: 22935696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
    Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
    Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16
    Al-Khalaf HH; Aboussekhra A
    Mol Carcinog; 2017 Mar; 56(3):985-999. PubMed ID: 27596953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of MEOX1 and MEOX2 regulation of the cyclin dependent kinase inhibitors p21 and p16 in vascular endothelial cells.
    Douville JM; Cheung DY; Herbert KL; Moffatt T; Wigle JT
    PLoS One; 2011; 6(12):e29099. PubMed ID: 22206000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SATB2, coordinated with CUX1, regulates IL-1β-induced senescence-like phenotype in endothelial cells by fine-tuning the atherosclerosis-associated p16
    Wu T; Wu Y; Jiang D; Sun W; Zou M; Vasamsetti SB; Dutta P; Leers SA; Di W; Li G
    Aging Cell; 2023 Feb; 22(2):e13765. PubMed ID: 36633253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.